• In conjunction with the American Association of Ophthalmic Oncologists and Pathologists

    Ocular Oncology & Pathology 2020: Collaboration Now More Than Ever

    Friday, Nov. 13
    Sands Expo/Venetian, Las Vegas

    Program Directors

    Dan S. Gombos, MD and Paul J. Bryar, MD

    Mission Statement

    The 2020 Ocular Oncology and Pathology Subspecialty Day aims to provide up-to-date and state-of-the-art discussions and debates and pathology diagnosis on the most common, interesting and controversial topics regarding tumors of the eye and adnexa. These include diagnostic tips, imaging information, currently available pathologic and molecular biologic diagnostic techniques, therapies therapies including laser, radiation, local and systemic chemotherapy, and novel emerging therapies.,. Information from this Subspecialty Day meeting can be applied to patients seen in most ophthalmology practices, such as those with ocular surface tumors in corneal practices, intraocular tumors in retina practices, and eyelid/orbital tumors in comprehensive and oculoplastic practices.

    Target Audience

    The intended target audience for this program is practicing ophthalmologists, residents in training and fellows.

    Education Level

    Intermediate, Advanced

    Program Objectives

    Upon completion of this activity, participants should be able to:

    • Identify clinical and pathologic features of certain tumors, such as uveal melanoma, retinoblastoma, and lymphoma.
    • Recognize prognostic features and testing that predict recurrence and mortality.
    • Identify and manage treatment complications such as second tumors and metastasis.
    • Understand current therapeutic options including areas of consensus and disagreement.
    • Recognize advances in liquid biopsies and ocular pathology.
    • Determine when a patient should be referred to an ocular oncology center and when to consult an ocular pathologist.

    CME Accreditation

    The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Attendees registered as exhibitors, spouses or guests are not eligible for CME credits.

    Find more information about CME.